News und Analysen
Rally Gains Momentum On Soft PCE Data
The S&P 500 (NYSE: SPY) extended its summer rally after softer-than-expected PCE price data. The data is the latest in a string of good news that will help lift the market into mid-summer. The
Bank of America, JPMorgan, Goldman Sachs Set For Dividend Growth?
Income-oriented investors can keep an eye on big banks including Bank of America (NYSE: BAC), JPMorgan Chase & Co. (NYSE: JPM) and Goldman Sachs Group Inc. (NYSE: GS), to see whether they opted to
The Nike Rebound Is Over; Buying Opportunity Ahead
Nike (NYSE: NKE) proved again that it can Just Do It when operating in an ever-changing business environment. The Q3 results and guidance prove the company’s resiliency but also give evidence of
Apple's Bull Run And Why It's Different
A funny thing has been happening on Wall Street recently. Some of the biggest and brightest tech stocks have received cautious downgrades from analysts despite posting significant returns this
Caterpillar, Terex, Manitowoc Near Buy Points As Building Booms
Heavy-equipment makers Caterpillar Inc. (NYSE: CAT), Terex Corporation (NYSE: TEX) and Manitowoc Company, Inc. (NYSE: MTW) are all approaching buy points as they dig their way out of price
Oilfield Services Growing Faster Than Wider Energy Sector
It’s sometimes said that markets can turn on a dime. That seemed to have happened with the energy sector, which was the huge 2022 winner, but the Energy Select Sector SPDR Fund (NYSEARCA: XLE) is
Discover Financial Forms Bullish Cup Pattern, Nearing Buy Point
The Discover card from Discover Financial Services (NYSE: DFS) may not be as widely accepted as cards from Visa Inc. (NYSE: V), Mastercard Inc. (NYSE: MA) or American Express Company (NYSE: AXP)
Is ESG Investing Dead? Fund Outflows Signal Tough Times
ESG investing is not dead, but ESG investing as an investment thesis might be. Fund outflows from ESG-related funds topped 75% in 2022 and have only worsened. The trend is not limited to the US
The Most Upgraded Stocks In Q2
The Q2 earnings reporting season is about to be unleashed, making now an excellent time to look at which stocks the analysts are paying attention to. Among the many ways to find this information
Nasdaq 100 Surge: Is A Pullback Imminent And How to Prepare?
The Invesco QQQ (NASDAQ: QQQ) ETF finished 3.79% higher the week ended June 16, with slight gains following the Federal Reserve’s pause on rate increases.
The tech-laden Nasdaq 100 has been an
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
After a pandemic pause, hip and knee replacements are back. Long-postponed surgeries are being rescheduled, which is bad for business at insurance companies like UnitedHealth Group Inc. (NYSE:
3 Reasons Why Google Could Be The Big Tech Stock Of The Summer
As we’ve noted this week, shares of Apple Inc (NASDAQ: AAPL) have just returned to fresh all-time highs, while those of Meta Platforms Inc (NASDAQ: META) are also soaring this year. But they’re
Tech Titans Propel QQQ: Is A Pullback Looming?
Year-to-date, technology has led the charge in the market's recovery. Without the remarkable performance of a handful of industry, global leading names, the market would be near flat on the year.
Navigating Risks in AI Small Cap Investments: Beyond the Hype
Artificial intelligence is a global theme right now in the markets. As a result, a lot of excitement and optimism surrounds the industry and companies that have positioned themselves within AI.For
TreeHouse Foods Near Buy Point With Focus On High-Margin Products
Shares of TreeHouse Foods Inc. (NYSE: THS) are branching out to new heights as the stock approaches a buy point, and is already actionable.
Illinois-based Treehouse specializes in private-label
Mullen Automotive’s Dilution Is Desperation
Shares of Mullen Automotive (NASDAQ: MULN) are down another 15% to trade back at the pre-split level near $.25. That’s a bitter pill to swallow for investors holding out hopes this company can
Boeing Stock, Is There Still Room for Investors to Go Long?
The Boeing Company (NYSE: BA) is one of the shining stars of the Dow Jones companies in 2023. The stock is up 16% as we approach the midpoint of 2023. This continues a rally that has pushed BA
3 Beaten Down High-Yield Investors Should Love
Value investing is the idea of buying high-quality stocks when they are cheap. The hard part about value investing is buying those stocks when they’re down. Usually, stocks are down for a reason
Rebound Rallies? The Dow's 2 Most Oversold Stocks Are Stabilizing
The U.S. stock market is in a bull market!
Last week’s big headline is undoubtedly good news but should’ve come with an asterisk. More specifically, the S&P 500 index closed up more than 20% from
For AI Exposure, Try Global Artificial Intelligence ETF
Unless you've been hiding under a rock, you should know about the artificial intelligence (AI) mania that has hooked mainstream attention. Numerous articles and videos talk about AI. The stock
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
The price-to-earnings ratio, or P/E ratio, is one of the most commonly used metrics in fundamental stock analysis. The division of share price by earnings per share (typically over the last 12
Apple Partnership Strengthens Unity Software's Investment Appeal
Unity Software (NYSE: U) saw its share price rocket higher Monday afternoon and closed the day up almost 20% after Apple (NASDAQ: AAPL) announced they are working together on the Apple Vision Pro
3 High-Yield Names The Institutions Are Buying
The way the institutions are flocking to values like Kohl’s (NYSE: KSS), Verizon (NYSE: VZ), and Walgreens Boots Alliance (NYSE: WBA), investors might begin to think the sell-side is preparing for
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry
IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde
Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um